knowledge -WSS

knowledge

author：entertainment 2025-08-19 15:01:42 - browse：9

There’s a specter haunting Wall Street.

It started in biotech, where companies making drugs for the obesity-related liver disease NASH saw their valuations crash on the assumption that GLP-1 weight loss treatments would cut them out of the market. Then the Ozempic panic came for dialysis firms, whose stocks fell about 20% in a single day on the news that Novo Nordisk’s medicine had delayed the progression of kidney disease in a study enrolling people with type 2 diabetes.

Now analysts from every sector are cranking out research notes on the disparate, dramatic, and often debatable implications of GLP-1 drugs’ growing popularity, said Jared Holz, a health care specialist at Mizuho Securities. Buy Bumble, sell McDonald’s. Short Pepsi, go long Louis Vuitton. Put your money in sectors that cater to a svelte and sated brand of consumer, and get out of the ones that rely on excess and compulsion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Explaining an after

WSS

Prime Medicine says its gene editing passes test in monkeys

Key Senate panel to consider PBM, drug pricing reform package

Humans aren't the only ones with an imagination. Rats have it too

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Lung cancer screening guidelines updated for cigarette smokers

leisure time

knowledge

focus

Medical records are filled with copy

Readout LOUD podcast: ESMO highlights & Roivant's big deal

How one medical school became remarkably diverse

Medicare proceeds with plan to claw back hospital funds

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Humans aren't the only ones with an imagination. Rats have it too

Hepatitis C has a cure — but many Americans still lack access to it

Bill would allow buprenorphine prescription for addiction via telehealth

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Wikipedia

More hospitals are billing patients as online messages surge

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Robert Kennedy Jr.'s presidential campaign attracts GOP

Humans aren't the only ones with an imagination. Rats have it too

House passes resolution saying Israel isn't a 'racist or apartheid state'

More hospitals are billing patients as online messages surge

hotspot

focus

leisure time

hotspot